Cite
HARVARD Citation
Al Bakir, I. et al. (n.d.). OP38 Developing a Cost-Effective Genomic Biomarker of Cancer Risk in Patients with Ulcerative Colitis using Low-Pass Whole Genome Sequencing of Unselected Endoscopic Biopsies: A Case-Control Study. Journal of Crohn's and colitis. pp. S035-S036. [Online].